Healthcare stocks, ranked
9 healthcare companies carry a curated rating, out of 98 we list in the sector. The table ranks them by our overall rating; the gap between price and DCF fair value is the argument, and the moat score is how defensible the business behind it is.
Data as of Jul 20, 2026, free, no account.
| Company | Price | DCF upside | Moat | Yield | Rating |
|---|---|---|---|---|---|
LLY Eli Lilly & Co. | $920.00 | +9% | 84 | 0.7% | 73 |
AZN.L AstraZeneca | £105.20 | +14% | 82 | 2.2% | 72 |
UNH UnitedHealth Group | $492.10 | +10% | 73 | 1.6% | 71 |
JNJ Johnson & Johnson | $146.20 | +15% | 76 | 3.4% | 70 |
ABBV AbbVie Inc. | $195.00 | +8% | 76 | 3.2% | 68 |
TMO Thermo Fisher Scientific | $520.00 | +15% | 80 | 0.3% | 68 |
GSK.L GSK plc | £14.60 | +20% | 71 | 4.0% | 68 |
MRK Merck & Co. | $82.00 | +28% | 75 | 3.5% | 66 |
PFE Pfizer Inc. | $28.30 | +24% | 60 | 5.9% | 61 |
The top three, argued properly
Every clause below is computed from the table above, and every reason comes with its risk in the same breath. No name gets a case without a counter case.
Rated 73 overall, on a moat score of 84, a price 9% below our DCF fair value and 60% return on equity on modest leverage. The rating blends valuation, quality and stability, so read the parts before you trust the total.
A fair value model is an argument, not a measurement. Most of its output sits in assumptions about the future that nobody can verify today.
Rated 72 overall, on a moat score of 82, a price 14% below our DCF fair value, a 2.2% dividend yield and 18% return on equity on modest leverage. The rating blends valuation, quality and stability, so read the parts before you trust the total.
A fair value model is an argument, not a measurement. Most of its output sits in assumptions about the future that nobody can verify today.
Rated 71 overall, on a moat score of 73, a price 10% below our DCF fair value and 25% return on equity on modest leverage. The rating blends valuation, quality and stability, so read the parts before you trust the total.
A fair value model is an argument, not a measurement. Most of its output sits in assumptions about the future that nobody can verify today.
Run your own numbers
A table is a starting point. These free calculators let you test what the numbers above mean for an actual position.
Other sectors
Educational information, not financial advice, and not a recommendation to buy anything. Ratings, moat scores and fair values are model outputs with real limitations, spelled out in the disclaimer and the methodology.